## Mechanism: 
- chimeric IgG1 monoclonal antibody: 
	- high affinity binds to soluble and possibly membrane-bound TNFα 
## Indications: 
- RA, AS, PsA, Crohn’s disease, ulcerative colitis, pediatric inflammatory bowel disease, and psoriasis. 
- Off-label in other diseases: 
	- granulomatosis with polyangiitis (Wegener granulomatosis), giant cell arteritis, Behcet's disease, uveitis, and sarcoidosis
## Adverse Effects
- increase the risk of 
	- bacterial infections and macrophage-dependent infections (including tuberculosis, fungal, and other opportunistic infections) 
	- skin cancers—including melanoma